Market Cap 8.40M
Revenue (ttm) 0.00
Net Income (ttm) -7.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 170,700
Avg Vol 37,050
Day's Range N/A - N/A
Shares Out 1.50M
Stochastic %K 24%
Beta -0.05
Analysts Sell
Price Target $25.00

Company Profile

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and ti...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 734 335 0468
Address:
3600 Green Court, Suite 350, Ann Arbor, United States
ZacksResearch
ZacksResearch Sep. 11 at 3:39 AM
$NDRA Q2: The story wasn't operations. It was the balance sheet. 🚀 ENDRA swung to a $160K profit from a $1.2M loss a year ago, largely driven by digital asset gains, not core operations. 💰 Cash totaled $1.7M, with $3.8M in restricted cash and a $1.9M Digital Asset Treasury. Operating cash burn improved to $0.9M. 👀 The next catalysts are clear: TAEUS commercialization, regulatory milestones, strategic partnerships and cash runway. Find more on NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-39532&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39532
0 · Reply
cannacollector
cannacollector Sep. 3 at 12:57 PM
$NDRA $8 🔥🎯🚀
0 · Reply
Buylocal
Buylocal Sep. 2 at 5:53 PM
$NDRA this always happens before they dump a ton of new shares. lol
0 · Reply
cannacollector
cannacollector Sep. 2 at 3:32 PM
$NDRA $8 here we come 🔥
0 · Reply
SHEROCKSMYSTOCKS
SHEROCKSMYSTOCKS Sep. 2 at 3:14 PM
$PPCB dont miss this low float cancer play! Who shorts these stocks 🤔 $VIVK $RITR $NDRA $BIAF
0 · Reply
DEEZNUTTS2112
DEEZNUTTS2112 Sep. 2 at 2:22 PM
$NDRA its ripping alright. From 5.27 to 6.40. I made my money thank you.
0 · Reply
DEEZNUTTS2112
DEEZNUTTS2112 Sep. 1 at 7:18 PM
$NDRA accumulation happening right now. Gonna rip
0 · Reply
FrostyOrbit
FrostyOrbit Aug. 30 at 9:45 PM
$NDRA The project has a very large resource footprint and is positioned as a potentially important non-U.S. Helium source at a time when helium supply is strategically constrained…
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 1:00 PM
$NDRA: 4 takeaways from Q2 earnings 📊 ENDRA posted Q2 net income of $160K. It reported a $1.2M loss last year. Digital asset gains made the difference. 💰 Cash stood at $1.7M. Restricted cash was $3.8M. The Digital Asset Treasury held $1.9M. Operating cash burn improved to $0.9M. 📈 Operating expenses rose to $1.5M. Other income reached $1.6M. Most of it came from digital asset gains. 👀 Investors will track cash runway. They will also watch commercialization, regulatory progress and strategic partnerships. Find more on NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-39403&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39403
0 · Reply
Mutant666
Mutant666 Aug. 25 at 11:51 PM
$ASPI $NDRA RedChip events 15th and 17th.
0 · Reply
Latest News on NDRA
ENDRA Life Sciences Quarterly report: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 4 weeks ago

ENDRA Life Sciences Quarterly report: Q2 2026


ENDRA Life Sciences Earnings release: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 4 weeks ago

ENDRA Life Sciences Earnings release: Q2 2026


ASP Isotopes Issues Letter to Shareholders

Aug 4, 2026, 8:00 AM EDT - 6 weeks ago

ASP Isotopes Issues Letter to Shareholders

ASPI


ENDRA Life Sciences Inc trading resumes

2026-06-25T13:40:30.000Z - 2 months ago

ENDRA Life Sciences Inc trading resumes


ENDRA Life Sciences Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 4 months ago

ENDRA Life Sciences Quarterly report: Q1 2026


ENDRA Life Sciences Inc trading resumes

2026-05-13T19:48:18.000Z - 4 months ago

ENDRA Life Sciences Inc trading resumes


ENDRA Life Sciences Annual report: Q4 2025

Mar 31, 2026, 4:00 PM EDT - 5 months ago

ENDRA Life Sciences Annual report: Q4 2025


ENDRA Life Sciences Earnings release: Q4 2025

Mar 31, 2026, 4:00 PM EDT - 5 months ago

ENDRA Life Sciences Earnings release: Q4 2025


Endra Life Sciences initiates review of strategic alternatives

2026-03-25T12:06:25.000Z - 5 months ago

Endra Life Sciences initiates review of strategic alternatives


ENDRA Life Sciences Earnings release: Q3 2025

Nov 14, 2025, 7:00 AM EST - 10 months ago

ENDRA Life Sciences Earnings release: Q3 2025


ENDRA Life Sciences Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 10 months ago

ENDRA Life Sciences Quarterly report: Q3 2025


ENDRA Life Sciences Registration statement: Registration Filing

Nov 6, 2025, 7:00 AM EST - 10 months ago

ENDRA Life Sciences Registration statement: Registration Filing


ENDRA Life Sciences Proxy statement: Proxy Filing

Oct 28, 2025, 8:00 AM EDT - 10 months ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Proxy statement: Proxy Filing

Oct 28, 2025, 8:00 AM EDT - 10 months ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Proxy statement: Proxy Filing

Oct 17, 2025, 8:00 AM EDT - 11 months ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Earnings release: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 1 year ago

ENDRA Life Sciences Earnings release: Q2 2025


ENDRA Life Sciences Quarterly report: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 1 year ago

ENDRA Life Sciences Quarterly report: Q2 2025


ENDRA Life Sciences Quarterly report: Q1 2025

May 15, 2025, 12:30 PM EDT - 1 year ago

ENDRA Life Sciences Quarterly report: Q1 2025


ENDRA Life Sciences Earnings release: Q1 2025

May 15, 2025, 12:30 PM EDT - 1 year ago

ENDRA Life Sciences Earnings release: Q1 2025


ENDRA Life Sciences Inc trading resumes

2025-05-09T14:02:48.000Z - 1 year ago

ENDRA Life Sciences Inc trading resumes


ENDRA Life Sciences Earnings release: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

ENDRA Life Sciences Earnings release: Q4 2024


ENDRA Life Sciences Annual report: Q4 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

ENDRA Life Sciences Annual report: Q4 2024


ENDRA Life Sciences Inc trading resumes

2024-11-29T16:15:26.000Z - 1 year ago

ENDRA Life Sciences Inc trading resumes


ENDRA Life Sciences Quarterly report: Q3 2024

Nov 15, 2024, 4:00 PM EST - 1 year ago

ENDRA Life Sciences Quarterly report: Q3 2024


ENDRA Life Sciences Earnings release: Q3 2024

Nov 15, 2024, 4:00 PM EST - 1 year ago

ENDRA Life Sciences Earnings release: Q3 2024


ENDRA Life Sciences Proxy statement: Proxy Filing

Sep 17, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Proxy statement: Proxy Filing

Sep 16, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Proxy statement: Proxy Filing

Sep 6, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Earnings Call Transcript: Q2 2024

Aug 22, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings Call Transcript: Q2 2024


ENDRA Life Sciences Quarterly report: Q2 2024

Aug 22, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Quarterly report: Q2 2024


ENDRA Life Sciences Earnings release: Q2 2024

Aug 22, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings release: Q2 2024


ENDRA Life Sciences Announces Reverse Stock Split

Aug 16, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Announces Reverse Stock Split


ENDRA Life Sciences Announces Leadership Changes

Aug 13, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Announces Leadership Changes


ENDRA Life Sciences Proxy statement: Proxy Filing

Jul 17, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Proxy statement: Proxy Filing

Jun 25, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Proxy statement: Proxy Filing

Jun 25, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Proxy statement: Proxy Filing

Jun 12, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Proxy statement: Proxy Filing


ENDRA Life Sciences Registration statement: Registration Filing

May 31, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Registration statement: Registration Filing


ENDRA Provides Update Following In-person Meeting with FDA

May 20, 2024, 8:00 AM EDT - 2 years ago

ENDRA Provides Update Following In-person Meeting with FDA


ENDRA Life Sciences Earnings Call Transcript: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings Call Transcript: Q1 2024


ENDRA Life Sciences Quarterly report: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Quarterly report: Q1 2024


ENDRA Life Sciences Earnings release: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings release: Q1 2024


ENDRA Life Sciences Registration statement: Registration Filing

May 10, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Registration statement: Registration Filing


ENDRA Life Sciences Registration statement: Registration Filing

Apr 19, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Registration statement: Registration Filing


ENDRA Life Sciences Earnings Call Transcript: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings Call Transcript: Q4 2023


ENDRA Life Sciences Annual report: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Annual report: Q4 2023


ENDRA Life Sciences Earnings release: Q4 2023

Mar 28, 2024, 4:30 PM EDT - 2 years ago

ENDRA Life Sciences Earnings release: Q4 2023


ENDRA Life Sciences Registration statement: Registration Filing

Mar 28, 2024, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences Registration statement: Registration Filing


ENDRA Life Sciences Installs First TAEUS System in the UK

Feb 27, 2024, 8:00 AM EST - 2 years ago

ENDRA Life Sciences Installs First TAEUS System in the UK


ENDRA Life Sciences Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

ENDRA Life Sciences Registration statement: Registration Filing


ENDRA Life Sciences Earnings Call Transcript: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

ENDRA Life Sciences Earnings Call Transcript: Q3 2023


ENDRA Life Sciences Quarterly report: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

ENDRA Life Sciences Quarterly report: Q3 2023


ENDRA Life Sciences Earnings release: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

ENDRA Life Sciences Earnings release: Q3 2023


ZacksResearch
ZacksResearch Sep. 11 at 3:39 AM
$NDRA Q2: The story wasn't operations. It was the balance sheet. 🚀 ENDRA swung to a $160K profit from a $1.2M loss a year ago, largely driven by digital asset gains, not core operations. 💰 Cash totaled $1.7M, with $3.8M in restricted cash and a $1.9M Digital Asset Treasury. Operating cash burn improved to $0.9M. 👀 The next catalysts are clear: TAEUS commercialization, regulatory milestones, strategic partnerships and cash runway. Find more on NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-39532&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39532
0 · Reply
cannacollector
cannacollector Sep. 3 at 12:57 PM
$NDRA $8 🔥🎯🚀
0 · Reply
Buylocal
Buylocal Sep. 2 at 5:53 PM
$NDRA this always happens before they dump a ton of new shares. lol
0 · Reply
cannacollector
cannacollector Sep. 2 at 3:32 PM
$NDRA $8 here we come 🔥
0 · Reply
SHEROCKSMYSTOCKS
SHEROCKSMYSTOCKS Sep. 2 at 3:14 PM
$PPCB dont miss this low float cancer play! Who shorts these stocks 🤔 $VIVK $RITR $NDRA $BIAF
0 · Reply
DEEZNUTTS2112
DEEZNUTTS2112 Sep. 2 at 2:22 PM
$NDRA its ripping alright. From 5.27 to 6.40. I made my money thank you.
0 · Reply
DEEZNUTTS2112
DEEZNUTTS2112 Sep. 1 at 7:18 PM
$NDRA accumulation happening right now. Gonna rip
0 · Reply
FrostyOrbit
FrostyOrbit Aug. 30 at 9:45 PM
$NDRA The project has a very large resource footprint and is positioned as a potentially important non-U.S. Helium source at a time when helium supply is strategically constrained…
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 1:00 PM
$NDRA: 4 takeaways from Q2 earnings 📊 ENDRA posted Q2 net income of $160K. It reported a $1.2M loss last year. Digital asset gains made the difference. 💰 Cash stood at $1.7M. Restricted cash was $3.8M. The Digital Asset Treasury held $1.9M. Operating cash burn improved to $0.9M. 📈 Operating expenses rose to $1.5M. Other income reached $1.6M. Most of it came from digital asset gains. 👀 Investors will track cash runway. They will also watch commercialization, regulatory progress and strategic partnerships. Find more on NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-39403&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39403
0 · Reply
Mutant666
Mutant666 Aug. 25 at 11:51 PM
$ASPI $NDRA RedChip events 15th and 17th.
0 · Reply
ZacksResearch
ZacksResearch Aug. 21 at 2:20 PM
$NDRA: What investors should watch after Q2 earnings 📊 ENDRA remained a pre-revenue company in Q2 while continuing to advance its TAEUS ultrasound platform toward commercialization. 💰 The company ended the quarter with $1.7M in cash, $3.8M in restricted cash and $1.9M in its Digital Asset Treasury, while operating cash burn improved to $0.9M from $1.1M a year ago. 📈 Operating expenses rose to $1.5M, largely due to higher stock-based compensation, even as liquidity remained a key focus. 👀 Investors will be watching cash runway, commercialization milestones, regulatory progress and potential strategic partnerships. Find more on NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-39341&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39341
0 · Reply
focafoca99
focafoca99 Aug. 17 at 8:24 PM
$NDRA posted its June 30, 2026 quarter results in a press release attached to the 8-K.
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 3:44 PM
$NDRA valuation check 📊 NDRA currently trades at 3.6x forward sales, well below its recent peak valuation of 6.3x despite advancing toward commercialization of its TAEUS liver imaging platform. As regulatory and commercial milestones begin to unfold, any improvement in execution could support a re-rating toward historical multiples. The current valuation leaves room for upside if the company delivers on adoption and revenue growth. Find more on $NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-39150&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39150
0 · Reply
ZacksResearch
ZacksResearch Jul. 31 at 12:53 PM
$NDRA: What investors should watch heading into Q2 earnings 📊 ENDRA continued operating as a pre-revenue company in Q1 while advancing its TAEUS ultrasound technology toward commercialization. 💰 Net loss came in at $1.3M, or $1.09 per share, versus $1.0M, or $1.86 per share, in the prior-year quarter. 🏥 The quarter was centered on regulatory execution, technology development and laying the groundwork for future market adoption. 👀 As Q2 results approach, investors will be focused on regulatory progress, commercialization timelines, cash runway and any updates on strategic partnerships. Find more on $NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-39050&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_39050
0 · Reply
ZacksResearch
ZacksResearch Jul. 23 at 2:18 PM
$NDRA: looking back at the Q1 development story 📊 📈 The company remained in its pre-revenue stage as it continued advancing its TAEUS platform. 💵 Net loss totaled $1.3M, or $1.09 per share, compared with $1.0M, or $1.86 per share, a year earlier. 🏥 Management has remained focused on regulatory progress and preparing TAEUS for broader market adoption. 👀 With Q2 earnings due next month, investors will be looking for updates on regulatory milestones, commercialization plans and financing. Find more on NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-38941&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_38941
0 · Reply
Buylocal
Buylocal Jul. 21 at 10:35 PM
$NDRA looks like it’s time to increase share count. Been claiming all the other data for 5 years. FDA not buying it.
0 · Reply
Gainprofit
Gainprofit Jul. 21 at 3:06 PM
$NDRA 👀 still watching this one moving slowly
0 · Reply
ZacksResearch
ZacksResearch Jul. 17 at 12:02 PM
$NDRA Q1 2026 Financial Highlights: • Cash used in operations improved to $1.1M from $1.3M in Q1 2025. • Operating expenses rose to $2.2M from $1.5M, while net loss widened to $1.3M from $1.0M. • Ended Q1 with $356K in cash and cash equivalents, plus ~$2.4M held in its Digital Asset Treasury. Find more on NDRA here 👉 https://www.zacks.com/stock/quote/NDRA?cid=sm-stocktwits-0-quote_overview-oc-38835&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_38835
0 · Reply